---
title: "预览：Eikon Therapeutics, Inc 将于明日进行首次公开募股"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/274836033.md"
description: "Eikon Therapeutics, Inc 将于 2026 年 2 月 5 日在纳斯达克上市，股票代码为 EIKN。预计每股价格在 16.00 美元至 18.00 美元之间，内部锁定期为 180 天，将于 2026 年 8 月 4 日结束。该公司专注于开发针对严重未满足医疗需求的创新药物"
datetime: "2026-02-04T15:00:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274836033.md)
  - [en](https://longbridge.com/en/news/274836033.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274836033.md)
---

# 预览：Eikon Therapeutics, Inc 将于明日进行首次公开募股

**Eikon Therapeutics, Inc** (NASDAQ:EIKN) IPO will take place February, 05 on the NASDAQ exchange under the ticker EIKN.

The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on August 04, 2026.

**See also:** **Benzinga IPO Calendar**

### About Eikon Therapeutics, Inc

Eikon Therapeutics, Inc is a late-stage clinical biopharmaceutical company dedicated to building a global, fully-integrated organization developing important, innovative medicines to address serious unmet medical needs.

**See also:** **Benzinga's Most Shorted Stocks**

_This article was generated by Benzinga's automated content engine and reviewed by an editor._

### 相关股票

- [BIB.US](https://longbridge.com/zh-CN/quote/BIB.US.md)
- [XBI.US](https://longbridge.com/zh-CN/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [FBT.US](https://longbridge.com/zh-CN/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [ANIK.US](https://longbridge.com/zh-CN/quote/ANIK.US.md)
- [NBSE.ESC.US](https://longbridge.com/zh-CN/quote/NBSE.ESC.US.md)
- [PBE.US](https://longbridge.com/zh-CN/quote/PBE.US.md)

## 相关资讯与研究

- [Twist Bioscience Q2 营收增长 19% AI 药物发现需求强劲](https://longbridge.com/zh-CN/news/285111534.md)
- [ASCO 年会召开在即 国产创新药 LBA 数量创新高 三条投资主线值得关注](https://longbridge.com/zh-CN/news/285023794.md)
- [阿尼卡医疗｜8-K：2026 财年 Q1 营收 29.61 百万美元超过预期](https://longbridge.com/zh-CN/news/284558080.md)
- [GLP-1 博尽全力稳增长](https://longbridge.com/zh-CN/news/285284625.md)
- [阿尼卡医疗公布 2026 年第一季度财务业绩 | ANIK 股票新闻](https://longbridge.com/zh-CN/news/284554290.md)